AbbVie (NYSE:ABBV) Raised 2023 Adjusted Earnings Guidance

AbbVie(NYSE:ABBV) reported Q1 adjusted earnings  of $2.46 per diluted share, compared with $3.16 a year earlier. Analysts polled by Capital IQ expected $2.48. Net revenue for the quarter ended March 31 was $12.23 billion, compared with $13.54 billion a year earlier. Analysts surveyed by Capital IQ expected $12.25 billion. The company raised its adjusted earnings guidance for full-year 2023 to $10.72 to $11.12 per diluted share from $10.62 to $11.02. Analysts polled by Capital IQ expect 2023 adjusted earnings of $10.95.

AbbVie (NYSE:ABBV) Raised 2023 Adjusted Earnings Guidance Read Post »

Snap(NYSE:SNAP) Q1 Sales $988.61M Miss $1.01B Estimate

Snap (NYSE:SNAP) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) . The company reported quarterly sales of $988.61 million which missed the analyst consensus estimate of $1.01 billion by 2.12 percent. “Our community continues to grow, reaching 383 million daily active users in Q1, and we are working to deepen engagement with our content platform while building innovative new features and services like My AI,” said Evan Spiegel, CEO. “We are working to accelerate our revenue growth and we are using this opportunity to make significant improvements to our advertising platform to help drive increased return on investment for our advertising partners.” Q1 2023 Financial Summary •Revenue was $989 million, compared to $1,063 million in the prior year. •Net loss was $329 million, compared to $360 million in the prior year. •Adjusted EBITDA was $1 million, compared to $64 million in the prior year.

Snap(NYSE:SNAP) Q1 Sales $988.61M Miss $1.01B Estimate Read Post »

Scroll to Top